Events & presentations

Financial & IR calendar

2022 Full year results

7 March 2023

Berenberg EU Opportunities Conference 2023

14 March 2023
London

2022 Annual report

18 April 2023

Kempen Life Sciences Conference

25 April 2023
Amsterdam

Euronext Tech Leaders Nordic Investor Conference

23 May 2023
Oslo

General Shareholders’ Meeting

25 May 2023

2023 Interim report

26 September 2023

Investor Relations
presentation

Investor Relations
factsheet

Investor
Day

Presentations & webcasts

Material
Date
View

Donesta partnership webcast

20 December 2022

Pharmaceuticals in the Environment: Current challenges and tomorrow’s solutions to protect wildlife

8 November 2022

Efficacy and Safety of Estetrol (E4), a Promising New Treatment for Menopausal Vasomotor Symptoms: Results of a randomized, double- blind, placebo-controlled Phase 3 trial (North American Menopause Society 2022 meeting 12-15 Oct, Atlanta, GA)

14 October 2022

Estetrol (E4), a landmark in the making? Before and beyond reproductive age: new therapeutic opportunities for E4 ⁠- Report on Scientific Symposium (20th ISGE World Congress)

13 June 2022

2021 Annual Results Webcast

8 March 2022

Donesta® Top-Line Results Phase 3

14 January 2022

2021 Investor Day Webcast

29 November 2021

2021 Half Year Results Webcast

24 September 2021

Estrogens: Harnessing the power of nature against Covid-19 and emerging viral infections – Presentation

28 May 2021

2020 Annual Results Webcast (9.30 CET) ( Virtual )

9 March 2021

Share price

01/02/2023 17:35 (Euronext Brussels)

€ 3.18

+0.06

(+1.92%)

Calendar & events

2022 Full year results
7 March 2023
Berenberg EU Opportunities Conference 2023
14 March 2023
London
2022 Annual report
18 April 2023

Investor Relations

Benoît Mathieu

Get the latest news: subscribe to our Newsletter!